However, empagliflozin did not improve diabetes-induced albuminuria, increased urinary markers of tubule damage (KIM-1 and NGAL), renal hypertrophy, or glomerulosclerosis, when administered alone or in combination with metformin. This evidence concerns the gene HAVCR1 and glomerulosclerosis.